Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-17-007030
Filing Date
2017-11-30
Accepted
2017-11-30 13:25:48
Documents
1
Period of Report
2017-11-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-40364.html 4  
1 PRIMARY DOCUMENT marketforms-40364.xml 4 10251
  Complete submission text file 0001214659-17-007030.txt   11690
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
Intiva BioPharma Inc. (Issuer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 6770 Blank Checks

Mailing Address 101 CENTRAL PARK WEST NEW YORK NY 10023
Business Address
Bankier Alain D (Reporting) CIK: 0001719591 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55320 | Film No.: 171230712